Improving awareness of women with hypertension: roar (rural, obese, at risk) - more than 1 in 3 women are living with heart disease and many are unaware of the risks
Active Cooperative Agreement Awarded Last action
- Award ID
- U54HL169191
- Recipient
-
Augusta University Research Institute, Inc. UEI N4WWJC8T2593 Part of Board Of Regents Of The University System Of Georgia
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,451,320
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date 63% complete
- Funding agency
- Office of the Director National Institutes of Health, Department of Health and Human Services
- Place of performance
- Augusta, GA 30912, USA
Award details come from USAspending.gov.
Description
Hypertension is a major modifiable risk factor for cardiovascular disease (CVD), and ~47% of adults in the US have hypertension. In ~85% of cases, the cause of hypertension is unknown and only ~50% of patients taking medication achieve blood pressure (BP) control to recommended levels. A critical barrier to limiting premature death from CVD is lack of awareness surrounding the risks of CVD. Our location in the southeast of the US will contribute to our impact. The prevalence of hypertension and obesity are high in GA, MS, and SC. The prevalence of hypertension and associated risk is not equal among all populations. Indeed, the prevalence of hypertension in black people in the US is among the highest in the world. Our overall goal is to transform academic and community understanding of SEX as a biological variable (sabv) in the consideration of hypertension. We will accomplish this through the creation and dissemination of innovative educational content, the development of strategic partnerships, and enhanced community engagement in the southeast of the US. This score is designed to provide novel insight into the mechanisms controlling BP in females VS. Males, develop a comprehensive educational platform on sabv in CVD extending from grade school to medical school, and increase awareness and education of CVD and the risks of uncontrolled hypertension in women across the health span through community outreach. This score has 4 objectives. Objective 1 is to conduct cutting edge research to advance our understanding of SEX-specific mechanisms that control BP to limit cardiovascular risk. Objective 2 is to develop a culturally diverse research pipeline of biomedical scientists trained in the field of sabv in CVD. Objective 3 is to establish a community outreach pipeline of trained scientists to increase awareness of sabv and promote optimal cardiovascular healthcare for men and women. Objective 4 is to empower the community to self-monitor and work to identify barriers to improving access to healthcare. The outcomes of our proposed score include not only advances in science and training of the next generation of leaders in the study of the impact of biological SEX on the development and progression of CVD, but also the development of a range of educational content that will be fully available to the consortium. This will include 1) the development educational materials by medical illustrators for students/trainees at all stages, the community, and physicians, 2) establishing a sabv mentoring academy, 3) creating a sabv curriculum and workshop for students, fellows, and junior investigators. The impact of our work will be to increase recognition and awareness of the risks of CVD and hypertension to women across their health span and best practices for savb experimental design. Our comprehensive community outreach plan will also be critical to reach a highly at-risk population in the southeast of the US to increase routine cardiovascular health monitoring and decrease the overall CVD burden on both the population and the healthcare system.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $475,504 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $1,000,000 | |
| Amendment | $1,000,000 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $469,903 | |
| Amendment | $0 | |
| Original award | $505,913 |
Show all 11
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| University Of South Carolina | $9,231 | |
| University Of South Carolina | $30,859 | |
| University Of South Carolina | $317,398 | |
| University Of South Carolina | $21,885 | |
| University Of South Carolina | -$21,885 | |
| University Of South Carolina | $0 | |
| University Of Mississippi Medical Center | $310,000 | |
| University Of South Carolina | $9,231 | |
| University Of South Carolina | $30,859 | |
| University Of South Carolina | $317,398 | |
| University Of South Carolina | $0 | |
| University Of Mississippi Medical Center | $310,000 | |
| University Of South Carolina | $320,143 | |
| University Of South Carolina | $30,859 | |
| University Of South Carolina | $9,231 | |
| University Of South Carolina | $317,398 | |
| University Of South Carolina | $30,859 | |
| University Of South Carolina | $9,231 |
Show all 18
Quick answers
Who received award U54HL169191?
U54HL169191 was awarded to Augusta University Research Institute, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 1, 2023.
How much is award U54HL169191 worth?
$3,451,320 has been obligated on U54HL169191.
Which agency awarded U54HL169191?
National Heart Lung and Blood Institute (National Institutes of Health) awarded U54HL169191, with funding from Office of the Director (National Institutes of Health).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award